Subject demographics and related data
| FDG ID # | AV45 ID # | Age (y) | Sex | MMSE | Hach | GDS | SUVR | Months | Dx |
|---|---|---|---|---|---|---|---|---|---|
| 009_S_4388 | 009_S_4388 | 67 | M | 29 | 1 | 2 | 0.97 | 0.9 | MCI |
| 013_S_4580 | 013_S_4580 | 70 | F | 30 | 1 | 2 | 1.03 | 24 | Nl |
| 014_S_0520 | NA | 82 | F | 30 | 0 | 1 | 8.8 | MCI | |
| 014_S_4577 | 014_S_4577 | 85 | M | 29 | 1 | 0 | 1.17* | 0.8† | MCI |
| 027_S_5083 | 027_S_5083 | 74 | M | 28 | 0 | 1 | 1.05 | 24 | Nl |
| 032_S_4348 | 032_S_4348 | 66 | F | 30 | 0 | 5 | 1.42* | 7.2 | Nl |
| 033_S_4179 | 033_S_4179 | 83 | M | 30 | 1 | 1 | 1.53* | 52 | Nl |
| 082_S_4339 | 082_S_4339 | 84 | M | 29 | 1 | 0 | 1.41* | 25 | Nl |
Reference group matched for age (mean 75 years, range 60–94, SD 6) and education (mean 17 years, range 8–20). Months denote time interval between closest assessment and FDG PET (months to last diagnosis of normal after imaging; †months to last diagnosis of normal before imaging). *, amyloid positive (per ADNI). AV45, florbetapir; MMSE, Mini-Mental Status Exam score; Hach, Hachinski score; GDS, Geriatric Depression Scale; SUVR, standardized uptake value ratio (per ADNI); NA, scan not available/done; Nl, normal; MCI, mild cognitive impairment; Dx, last recorded diagnosis.